SINERGIA is a project funded by the EU in the framework of the H2020 Innovative Training Networks program. 15 PhD student positions are available in the consortium.
SINERGIA aims to provide breakthrough strategies for the implementation of new in vitro preclinical platforms in terms of innovative technologies, biological models and drug screening approaches in the effort of bridging the gap between current, simplistic in vitro cultures and faithful and effective future physiological models. The Consortium will enrol 15 Early Stage Researchers (ESRs = PhD students): 9 ESRs based at Universities, 4 ESRs at Companies, and 2 ESRs at Hospitals. Two of these ESR positions are available in MERLN.